Zhejiang Tailin BioEngineering Co.,Ltd

Equities

300813

CNE100003S89

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
20.47 ^CNY	+0.49%		-3.40%	-16.52%

05-20	Zhejiang Tailin Bioengineering Co.,Ltd Announces Final Dividend Implementation Per A Shares for the Year 2023, Payable on 27 May 2024	CI
04-24	Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023	CI

Zhejiang Tailin Bioengineering Co.,Ltd Announces Management Appointments

April 23, 2021 at 08:35 pm

Zhejiang Tailin BioEngineering Co.,Ltd appointed Ye Dalin; Ni Weiju; Shen Zhilin; and Xia Xinqun as non-independent directors and Yang Zhongzhi; Dong Ming; and Li Jicheng as independent directors. The company also elected Ni Xiaolu and Mo Jiangang as non-employee supervisors.

Latest news about Zhejiang Tailin BioEngineering Co.,Ltd

Zhejiang Tailin Bioengineering Co.,Ltd Announces Final Dividend Implementation Per A Shares for the Year 2023, Payable on 27 May 2024	05-20	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023	04-23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-23	CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	12-11	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 11 May 2023	27/04/23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
Zhejiang Tailin Bioengineering Co.,Ltd. Proposes Final Cash Dividend for 2022	03/04/23	CI
Certain A Shares of Zhejiang Tailin BioEngineering Co.,Ltd are subject to a Lock-Up Agreement Ending on 15-JAN-2023.	14/01/23	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	28/08/22	CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it has received CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	08/06/22	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022	10/05/22	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for the Year of 2021	19/04/22	CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	18/04/22	CI
Zhejiang Tailin Life Science Co., Ltd. announced that it expects to receive CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd	17/04/22	CI
Zhejiang Tailin Bioengineering Sells $33 Million RMB Convertible Bonds	29/12/21	MT
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	29/08/21	CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2020, Payable on May 26 , 2021	18/05/21	CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Dividend for 2020	26/04/21	CI
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	25/04/21	CI
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	25/04/21	CI

Chart Zhejiang Tailin BioEngineering Co.,Ltd

Duration

Period

Chart Zhejiang Tailin BioEngineering Co.,Ltd

More charts

Company Profile

Zhejiang Tailin Bioengineering Co., Ltd. is a China-based company mainly engaged in pharmaceutical equipment business. The Company's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The Company distributes its products within domestic market and to overseas markets.

Sector

Advanced Medical Equipment & Technology

Calendar

25/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ZHEJIANG TAILIN BIOENGINEERING CO.,LTD	-16.52%	307M
THERMO FISHER SCIENTIFIC	+7.87%	223B
DANAHER CORPORATION	+11.83%	195B
INTUITIVE SURGICAL, INC.	+18.87%	144B
BOSTON SCIENTIFIC CORPORATION	+30.03%	111B
SIEMENS HEALTHINEERS AG	+2.32%	65.19B
EDWARDS LIFESCIENCES CORPORATION	+14.15%	53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.68%	50.28B
AGILENT TECHNOLOGIES, INC.	+6.60%	44.15B
GE HEALTHCARE TECHNOLOGIES INC.	+1.85%	36.45B

Other Advanced Medical Equipment & Technology